Hillmer, A. M., Ng, K.-P., Chuah, C., Juan, W. C., Ko, T.-K., Teo, A. S. M., … Ong, S. T. (2011). A Common Deletion Polymorphism in the BIM Gene Contributes to Intrinsic Imatinib Resistance in Chronic Myelogenous Leukemia. In BLOOD (Vol. 118, pp. 724–724). San Diego, CA: AMER SOC HEMATOLOGY.

Hillmer, Axel M., King-Pan Ng, Charles Chuah, Wen Chun Juan, Tun-Kiat Ko, Audrey S. M. Teo, Pramila N. Ariyaratne, et al. “A Common Deletion Polymorphism in the BIM Gene Contributes to Intrinsic Imatinib Resistance in Chronic Myelogenous Leukemia.” In BLOOD, 118:724–724. AMER SOC HEMATOLOGY, 2011.

Hillmer AM, Ng K-P, Chuah C, Juan WC, Ko T-K, Teo ASM, et al. A Common Deletion Polymorphism in the BIM Gene Contributes to Intrinsic Imatinib Resistance in Chronic Myelogenous Leukemia. In: BLOOD. AMER SOC HEMATOLOGY; 2011. p. 724–724.

Hillmer, Axel M., et al. “A Common Deletion Polymorphism in the BIM Gene Contributes to Intrinsic Imatinib Resistance in Chronic Myelogenous Leukemia.” BLOOD, vol. 118, no. 21, AMER SOC HEMATOLOGY, 2011, pp. 724–724.

Hillmer AM, Ng K-P, Chuah C, Juan WC, Ko T-K, Teo ASM, Ariyaratne PN, Takahashi N, Sawada K, Fei Y, Lee WH, Huang W, Allen JC, Woo XT, Nagarajan N, Kumar V, Thalamuthu A, Poh WT, Ang AL, Mya HT, How GF, Yang LY, Koh LP, Nadarajan VS, Chng W-J, Than H, Lim LC, Goh Y-T, Noethen MM, Wong TY, Shahab A, Ruan X, Cacheux-Rataboul V, Sung W-K, Ruan Y, Ong ST. A Common Deletion Polymorphism in the BIM Gene Contributes to Intrinsic Imatinib Resistance in Chronic Myelogenous Leukemia. BLOOD. AMER SOC HEMATOLOGY; 2011. p. 724–724.